
CHF fellow. Researcher in @theamrhub. Passionate about research relating to microbiology, STIs, infertility and pregnancy. Views my own. She/her/Dr
Brisbane, Australia
Joined October 2013
- Tweets1.2K
- Following263
- Followers335
- Likes2.9K
Dr Emma Sweeney retweeted
Huge congratulations to Dr. @ericalplummer! 🎉 Her research in understanding of non-gonococcal urethritis, cervicitis, and bacterial vaginosis was celebrated at the recent @theamrhub symposia, highlighting emerging leaders in the field.
Dr Emma Sweeney retweeted
📢New case study! A #REDI Fellowship brought researcher Dr Emma Sweeney together with molecular diagnostic company @speedx, to develop new precision medicine treatment strategies for sexually transmitted superbug Mycoplasma genitalium. Find out more🧪 bit.ly/40cwPQ6
Dr Emma Sweeney retweeted
Recommend applying for this opportunity to get behind the scenes and be a part of an International editorial team at the journal STI!
#Vacancy - Editorial Fellows
bit.ly/3ZCzORl
We have an exciting for you to join our Editorial team.
We have a vacancy for 2-3 Editorial Fellows, the deadline is 21st October 2024!
Dr Emma Sweeney retweeted
After a long gestation, the first paper from my PhD project is out! Read all about preterm blood volume 👇🏼
🩸doi.org/10.1038/s41390-024-0…🩸
Not possible without my amazing supervisors @YvonneEiby @babakrania @UQ_Perinatal #UQCCR @UQMedicine @UQ_News @UQHealth @Ped_Research
Dr Emma Sweeney retweeted
Replying to @theMJA
@theMJA Insight discuss the 2023 consensus statement on the use of doxy‐PEP in Australia and highlight important considerations raised by AMR hub researchers concerning the threat of #AMR and the need to monitor the use and impact of doxy-PEP.
New clinical advice has prompted warnings from experts about a possible increase in antimicrobial resistance due to doxy-PEP use in treating STIs
ow.ly/wwnX50Ra6er
Dr Emma Sweeney retweeted
Our @theMJA Perspective
‘Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations’
Takeaway:
🥇AMR monitoring system
🥈doxy-PEP implementation
@ScienceNerdEmma @Jake_T_PhD @fabian_kong @UQMedicine #UQCCR
onlinelibrary.wiley.com/doi/…
Dr Emma Sweeney retweeted
Hot off the press 🔥 Hub researchers respond to the @ASHM #DoxyPEP consensus statement, particularly challenges around surveillance and the threat of #AMR @SaraFEBell @ScienceNerdEmma @fabian_kong @Jake_T_PhD @MSHCResearch @MicroDx_UQ @UQMedicine #UQCCR doi.org/10.5694/mja2.52255
Dr Emma Sweeney retweeted
Recently Australia released its statement on the use of DoxyPEP. Here is our response regarding challenges in surveillance and of course, AMR issues
doi.org/10.5694/mja2.52255
ASHM statement here ashm.org.au/about/news/doxy-…
@SaraFEBell @ScienceNerdEmma @MicroDx_UQ @SexHealthUoM
Dr Emma Sweeney retweeted
Insane achievement by @nguyen_tmt. First grant, as CIA *and* in your PhD no less? Tick! ✅
This Post is from an account that no longer exists. Learn more
Dr Emma Sweeney retweeted
Ertl et al. found that dual ParC-S83I and GyrA-M95I mutations are common in Australian Mycoplasma genitalium, particularly in the MG191 STs 130 and 146:
doi.org/10.1093/jac/dkad373
@ScienceNerdEmma @OUPMedicine @OxfordJournals #JACNews
Dr Emma Sweeney retweeted
🚨New review out now!
Congrats to first author @FazelehEtebar !
We discuss brain🧠and retinal👁️imaging tools for non-invasively studying microglia in vivo in Alzheimer's disease and MS 👇
frontiersin.org/articles/10.…
Dr Emma Sweeney retweeted
International travel can increase the risk of exposure to sexually transmissible infections. Our paper examines how pre-travel medical consultation can be used to provide targeted sexual health travel-related advice publish.csiro.au/sh/Fulltext…
Dr Emma Sweeney retweeted
Hot off the press! 🔥 A new article by @EllaTrem and team looking at oral papillomavirus co-infection with #gonorrhoea and #chlamydia doi.org/10.1017/S09502688230…
@UQMedicine #UQCCR @UQ_News
Dr Emma Sweeney retweeted
New publication from @ScienceNerdEmma and hub researchers! Concurrent parC-S83I and gyrA-M95I mutations are common in Queensland, Australia, and are common among two specific #Mgenitalium genotypes 👇
academic.oup.com/jac/advance…
Dr Emma Sweeney retweeted
Seeking a Genomic Epidemiologist to work with our Public Health Virology and Microbiology genomics teams - permanent senior role, great conditions working on the frontline solving public health outbreaks. smartjobs.qld.gov.au/jobs/QL… #PublicHealth #Genomics #microbiology @AUSSOCMIC
Dr Emma Sweeney retweeted
The best of both worlds: a proposal for further integration of Candidatus names into the International Code of Nomenclature of Prokaryotes
#taxonomy
go.shr.lc/4aRBVUQ
Dr Emma Sweeney retweeted
Replying to @padstamundo @fordebm
Great work @padstamundo and @fordebm - wonderful team including @davidantibiotic @browsingcotta @kshekar01 👏🏼
Dr Emma Sweeney retweeted
New publication from @DrRanjitSamra and AMR hub researchers:
In a retrospective review of 229 cases, sitafloxacin cured 80.6% of macrolide-resistant Mgen infections. Prior failure of moxifloxacin was associated with an 8-fold increased odds of sitafloxacin failure.
It’s here! Presenting our paper on the efficacy of sitafloxacin in treating Mycoplasma genitalium 📝💊🦠
bit.ly/3RejD7a
@DrCatBradshaw @ericalplummer @lenkavod @EricPFChow @MSHCResearch
@IDSAInfo @HIVMA @OUPMedicine
Dr Emma Sweeney retweeted
Congratulations to #UQCCR Hub Researchers @ScienceNerdEmma, @Jake_T_PhD and @speedx, whose research partnership was awarded The University of Queensland EMCR Industry Engagement Award yesterday! @UQMedicine @MicroDx_UQ @UQ_News
Dr Emma Sweeney retweeted
Friendly reminder that the international Mycoplasma community has a home since 1976 => iom-online.org
2 years memberships at 100$, 30$ if you are a student.
Join a large and vibrant group of people studying mycoplasmas, and Mollicutes in general.

























